Healthcare -
Biotechnology - NASDAQ - US
$ 1.1857
-0.361 %
$ 65.3 M
Market Cap
-0.67
P/E
PRLD - GROSS PROFIT
Gross Profit PRLD - Prelude Therapeutics Incorporated
-1.17 M
LAST VALUE
27.81%
2 YEAR CAGR
-50.98%
5 YEAR CAGR
0.00%
10 YEAR CAGR